A risk assessment of clostridium difficile infection after antibiotherapy for urinary tract infections in the urology department for hospitalized patients

12Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Antibiotherapy is the treatment of choice for the urinary tract infections in hospitalized urological patients. Antibiotic associated diarrhea (ADD) caused by the Clostridium difficile cytotoxin producer represents one of the most severe side effects of the antibiotic treatment. It is important to evaluate the risk factors for a hospitalized patient to develop a C. difficile healthcare associated infection during hospitalization in order to put in practice effective preventive measures. The aim of the study is to analyzed the risk factors associated with the demographic status: Age, sex, and also risk factors related to healthcare conditions: use of antibiotics (number, type, duration of treatment), other significant medication taken prior to the onset of diarrhea (histamine-2-receptor antagonists and proton-pump inhibitors, comorbidities, possible contamination fromother in-patients who developed ADD in the same period and data about in-hospital mortality.

Cite

CITATION STYLE

APA

Grigore, N., Totan, M., Pirvut, V., Mitariu, S. I. C., Chicea, R., Sava, M., & Hasegan, A. (2017). A risk assessment of clostridium difficile infection after antibiotherapy for urinary tract infections in the urology department for hospitalized patients. Revista de Chimie, 68(7), 1453–1456. https://doi.org/10.37358/rc.17.7.5694

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free